- LVO thrombectomy trials were designed to confirm efficacy of the intervention in ideal patients.
- The benefit of thrombectomy in LVO is so powerful that many "trial-ineligible" patients are likely to derive benefit from the intervention.
- Future interventional trials ought to use a tiered approach to inclusion criteria or intervention type in order to maintain equipoise with randomization as a treatment benefit is observed in populations which are clearly expected to benefit.
11/10/2022 - 7:30am to 8:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. Jim Siegler